Botulinum toxin and quality of life in patients with facial paralysis

Archives of Facial Plastic Surgery

Volumn 10, Issue 2, 2008, Pages 84-87

  Mehta, Ritvik P ^a   Hadlock, Tessa A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FACIAL PARALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 41649084590     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.10.2.84     Document Type: Article

References (28)

1. Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology. 1999;53(7):1439-1446.
2. Velickovic M, Benabou R, Brin MF. Cervical dystonia pathophysiology and treatment options. Drugs. 2001;61(13):1921-1943.
3. Sulica L. Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg. 2004;12(6):543-548.
4. Berweck S, Heinen F. Use of botulinum toxin in pediatric spasticity (cerebral palsy). Mov Disord. 2004;19(suppl 8):S162-S167.
5. Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs. 2003;5(1):11-23.
6. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment: botulinum toxin A injections of the parotid glands. Med Hypotheses. 1997;48(4):337-339.
7. Khoo SG, Keogh IJ, Timon C. The use of botulinum toxin in Frey's syndrome. Ir Med J. 2006;99(5):136-137.
8. Kyrmizakis DE, Pangalos A, Papadakis CE, et al. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J Oral Maxillofac Surg. 2004;62(7):840-844.
9. Ozcan C, Vayisoglu Y, Dogu O, et al. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol. 2006; 27(5):314-318.
10. Cheshire WP, Freeman R. Disorders of sweating. Semin Neurol. 2003;23(4):399-406.
11. Matarasso A, Matarasso SL, Brandt FS, Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg. 1999;103(2):645-652.
12. Kane MA. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg. 1999;103(2):656-663.
13. Kane MA. The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg. 2005;21(1):55-64.
14. Kahn JB, Gliklich RE, Boyev KP, et al. Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope. 2001;111(3):387-398.
15. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989;84(2):353-355.
16. Roggenkämper P, Laskawi R, Damenz W, et al. Botulinum toxin treatment of synkinesia following facial paralysis. HNO. 1990;38(8):295-297.
17. Badarny S, Giladi N, Honigman S. Botulinum toxin injection effective for post-peripheral facial nerve palsy synkinesis. Harefuah. 1998;135(3-4):106-107, 167.
18. May M, Croxson GR, Klein SR. Bell's palsy: management of sequelae using EMG rehabilitation, botulinum toxin, and surgery. Am J Otol. 1989;10(3):220-229.
19. Mountain RE, Murray JA, Quaba A. Management of facial synkinesis with Clostridium botulinum toxin injection. Clin Otolaryngol Allied Sci. 1992;17(3):223-224.
20. Smet-Dieleman H, Van de Heyning PH, Tassignon MJ. Botulinum A toxin injection in patients with facial nerve palsy. Acta Otorhinolaryngol Belg. 1993;47(3):359-363.
21. Roggenkämper P, Laskawi R, Damenz W, et al. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol. 1994;86(4):395-402.
22. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 2005;115(2):573-574.
23. Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci. 1996;21(1):15-20.
24. Bulstrode NW, Harrison DH. The phenomenon of the late recovered Bell's palsy: treatment options to improve facial symmetry. Plast Reconstr Surg. 2005;115(6):1466-1471.
25. Krohel GB, Cipollo CL, Gaddipati K. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis. Am J Ophthalmol. 2005;139(3):540.
26. Finn JC. Botulinum toxin type A: fine-tuning treatment of facial nerve injury. J Drugs Dermatol. 2004;3(2):133-137.
27. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193-205.
28. Hadlock TA, Greenfield LJ, Wernick-Robinson M, et al. Multimodality approach to management of the paralyzed face. Laryngoscope. 2006;116(8):1385-1389.